Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Comment by Mil_Man54on Nov 05, 2021 11:09am
50 Views
Post# 34091987

RE:Next year FSD could be rocket mode depending on milestones

RE:Next year FSD could be rocket mode depending on milestonesWe're still waiting for Rosenberg to provide ONE post where we lied ot mislead investors.....he has been asked several times but hasn't provided anything....just comes back with baseless accussations because he can't disprove anything we post when calling him out for his attempts to mislead investors.....

DavidRosenberg wrote: WalterWhite ,  Jagpug , Mil_man54 are all shortsellers and paid stock bashers

all their lies and misleading statements trying to scare you guys away

If you want to sell the stock go ahead i could care less

If you want to buy the stock that's also your choice i dont care either

I care about the company doing proper results data driven clinical trials to grow shareholder value

I care about institutional investors that buy and hold the stock same like me

Thats who i care about , and offcourse the longs that are holding as well with me

ignore the shortseller basher trash scam artists here trying to paint a gloomy picture

sure stock is down from 2018.

Biotechs are often risky and warrant perfect execution and also good results before institutional investors even consider investing but I believe one day it could happen

3 drugs they have right now , 2 of which will need IND submission to FDA in 2022

UltramicroPEA could start phase 2 trials with another indication they only cancelled the ultramicroPEA trials for covid 19 under the advice of bloom burton

Competing company $ELYM also has PEA has their results due in first half of 2022 !

Cheers!


<< Previous
Bullboard Posts
Next >>